Susumu Eguchi | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Prof. Susumu Eguchi | Medicine and Dentistry | Best Researcher Award

Professor and Chairman from Nagasaki University Graduate School of Biomedical Sciences, Japan

Dr. Susumu Eguchi, M.D., Ph.D., F.A.C.S., F.E.B.S., is a globally recognized expert in the field of liver transplantation, hepatobiliary (HPB) surgery, and regenerative medicine. As a Professor and Chairman at the Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Dr. Eguchi has demonstrated outstanding leadership in both clinical and academic arenas. His medical journey is marked by international exposure, significant research contributions, and a wide array of prestigious editorial appointments. He has actively shaped the advancement of liver surgery, particularly focusing on liver regeneration and hepatocyte-based therapies. Dr. Eguchi’s dedication extends beyond national boundaries, with ongoing collaborations as a visiting professor in China and Kazakhstan, strengthening cross-cultural medical education and research. His active participation in hospital management, international medical center leadership, and nuclear disaster preparedness showcases his multifaceted expertise. Additionally, his editorial influence in several leading surgical and transplantation journals underlines his authority and commitment to knowledge dissemination. Throughout his distinguished career, Dr. Eguchi has significantly contributed to the global medical community and is highly regarded for his ability to combine innovative research with practical surgical excellence. His holistic approach and deep impact in the field make him a prominent figure deserving international recognition.

Professional Profile

Education

Dr. Susumu Eguchi’s educational journey is marked by rigorous academic training and international exposure that shaped his expertise in surgery and transplantation. He graduated from the Nagasaki University School of Medicine in 1992, where he developed a solid foundation in medical sciences. His dedication to deepening his knowledge led him to pursue a Ph.D. at the Nagasaki University Graduate School of Biomedical Sciences, Department of Surgery, from April 1994 to March 1998. This doctoral program was pivotal in advancing his surgical and research competencies, particularly in the hepatobiliary and liver transplantation domains. His international perspective was further broadened during his time at Cedars-Sinai Medical Center in the United States from 1994 to 1997, where he gained valuable experience in surgical research. Dr. Eguchi’s education provided him with a comprehensive blend of clinical, academic, and research-based learning that later translated into his significant contributions to the surgical field. The integration of both Japanese and Western medical training environments equipped him with a unique ability to lead innovative research and clinical practices. His academic progression reflects a consistent pursuit of excellence and positioned him to become an influential leader in liver transplantation and regenerative medicine.

Professional Experience

Dr. Susumu Eguchi has an extensive and distinguished professional career spanning over three decades, characterized by leadership roles in clinical practice, international collaborations, and academic governance. His journey began as a surgical trainee at Nagasaki University Hospital, and he further honed his skills at Cedars-Sinai Medical Center, focusing on surgical research. He has served in key positions such as Chief of Surgery at various hospitals, including National Tsushima Hospital and Nakatsushima Hospital. His international clinical fellowship at Groningen University Hospital in the Netherlands specialized in liver transplantation and hepatobiliary surgery, deepening his expertise in these fields. Since 2012, he has been a Professor at Nagasaki University Graduate School of Biomedical Sciences, where he also took on administrative roles, including Deputy Hospital Director and Director of the International Medical Center and Transplant Center. His global influence is evident through his visiting professorship at Guangzhou First Municipal People’s Hospital and Professor Emeritus roles at prestigious institutions in Kazakhstan and China. Dr. Eguchi’s career reflects a perfect balance of surgical excellence, academic leadership, and international outreach. His continuous involvement in both patient care and research highlights his dedication to advancing surgical techniques and improving patient outcomes globally.

Research Interest

Dr. Susumu Eguchi’s research interests are centered around advancing liver transplantation, hepatobiliary surgery, liver regeneration, and regenerative medicine. His work has significantly contributed to the development of liver surgery techniques and the enhancement of liver transplantation outcomes. A major focus of his research involves hepatocyte-based therapy, exploring the potential of regenerative treatments to restore liver function and improve long-term survival rates for patients. Dr. Eguchi is also deeply invested in liver regeneration studies, aiming to unravel cellular and molecular mechanisms that can accelerate or support liver recovery after surgery or damage. His commitment to hepatobiliary and pancreatic (HPB) surgery research integrates both clinical advancements and innovative therapies, addressing complex surgical challenges. Additionally, Dr. Eguchi has shown interest in disaster response and medical preparedness, applying his medical leadership to nuclear disaster situations. His broad research spectrum allows him to contribute to multidisciplinary fields, including surgical innovation, organ preservation, and post-operative recovery strategies. With his global perspective and cross-institutional collaborations, Dr. Eguchi continues to drive progress in improving surgical outcomes and patient care. His pioneering research offers promising solutions in regenerative medicine and solid organ transplantation, pushing the boundaries of modern surgical practices.

Research Skills

Dr. Susumu Eguchi possesses a wide range of research skills that reflect his technical mastery and innovative approach in the field of surgery and transplantation. He is highly skilled in complex liver surgery, hepatobiliary surgical techniques, and organ transplantation procedures. His research capabilities encompass hepatocyte-based therapy development, liver regeneration studies, and regenerative medicine applications. Dr. Eguchi is adept at designing clinical trials, managing multi-institutional research projects, and applying translational research principles to bridge laboratory findings with patient care improvements. His leadership in surgical research has been recognized internationally, contributing to advancements in both surgical methodologies and post-operative patient management. Moreover, Dr. Eguchi demonstrates strong skills in cross-cultural medical collaboration, contributing to the development of global treatment standards. His editorial roles across multiple high-impact journals also indicate his proficiency in critical peer review, scientific writing, and knowledge dissemination. He is experienced in guiding surgical teams, mentoring young researchers, and overseeing international research initiatives. Additionally, his involvement in disaster preparedness reflects his ability to integrate surgical expertise with public health strategies. Dr. Eguchi’s exceptional surgical and research skills collectively position him as a leading figure in the evolution of liver surgery and transplantation.

Awards and Honors

Dr. Susumu Eguchi has received numerous prestigious certifications and honors throughout his distinguished career, which underline his excellence and global recognition in the surgical community. He is a Fellow of the American College of Surgeons (F.A.C.S.), a Fellow of the European Board of Surgery (F.E.B.S.), a Fellow of the International College of Surgeons (F.I.C.S.), and has been recognized as an IASGO Fellow (FASGO) since 2023. His leadership and contributions have earned him honorary titles, such as Professor Emeritus at both Syzganovs’ National Scientific Centre of Surgery in Kazakhstan and The Second Affiliated Hospital to Nanchang University in China. Dr. Eguchi’s exceptional academic contributions are further demonstrated through his numerous editorial appointments in influential journals, including Transplantation, SURGERY, Hepatology Research, Journal of Hepato-Biliary-Pancreatic Science, and Annals of Gastroenterological Surgery. His editorial influence reflects his standing as an expert in the field and his commitment to advancing global surgical knowledge. These accolades not only validate his exceptional skills and research contributions but also emphasize his role as an international leader and innovator in liver transplantation and hepatobiliary surgery.

Conclusion

In conclusion, Dr. Susumu Eguchi is an outstanding and highly accomplished surgeon, educator, and researcher whose contributions to the fields of liver transplantation, hepatobiliary surgery, and regenerative medicine have had a profound impact both in Japan and internationally. His career is marked by an exceptional blend of clinical excellence, academic leadership, and global collaboration. Dr. Eguchi’s extensive research into liver regeneration and hepatocyte-based therapy offers significant advancements in surgical techniques and patient care. His ability to successfully bridge international academic relationships, lead hospital departments, and manage disaster preparedness initiatives highlights his multifaceted expertise. His prestigious fellowships, editorial leadership roles, and international professorships further attest to his global influence and professional recognition. Although future efforts to showcase quantitative research impact, such as citation metrics, could further solidify his academic profile, his achievements to date are exemplary. Dr. Eguchi continues to inspire the next generation of surgeons and researchers through his innovative work, extensive mentorship, and dedication to improving liver surgery outcomes worldwide. Based on his contributions and leadership, he is an exceptional candidate for recognition as a leading researcher and an ideal recipient of the Best Researcher Award.

Publications Top Notes

1. Transplantation of chemically induced liver progenitors in Nagase analbuminemic rats under liver regenerative stimulus

Authors: Masayuki Fukumoto, Akihiko Soyama, Daisuke Miyamoto, Takanobu Hara, Hajime Matsushima, Hajime Imamura, Mampei Yamashita, Tomohiko Adachi, Kengo Kanetaka, Susumu Eguchi
Year: 2025

2. Association Between Distance to the Transplant Center and Survival Following Living Donor Liver Transplantation

Authors: Hajime Matsushima, Akihiko Soyama, Takanobu Hara, Ayaka Kinoshita, Takashi Hamada, Kazushige Migita, Ayaka Satoh, Hajime Imamura, Tomohiko Adachi, Susumu Eguchi
Year: 2025

3. Effect on short‐term outcomes of the COVID‐19 pandemic following laparoscopic distal gastrectomy and low anterior resection for gastric and rectal cancer: A retrospective study using the Japanese National Clinical Database, 2018–2022

Authors: Masafumi Inomata, Hideki Endo, Tomonori Akagi, Hidefumi Shiroshita, Shigeki Yamaguchi, Susumu Eguchi, Norihito Wada, Yukinori Kurokawa, Yosuke Seki, Yoshiharu Sakai, et al.
Year: 2025

4. Limitations of the proposed lymph node classification in intrahepatic cholangiocarcinoma

Author: Susumu Eguchi
Year: 2025

5. Annual report on National Clinical Database 2021 for gastroenterological surgery in Japan

Authors: Sunao Ito, Arata Takahashi, Hideki Ueno, Shuji Takiguchi, Yoshiki Kajiwara, Yoshihiro Kakeji, Susumu Eguchi, Takanori Goi, Akio Saiura, Akira Sasaki, et al.
Year: 2025

6. Histopathological Downgrading of Borderline Phyllodes Tumor in a Young Patient Following Chemotherapy: A Case Report

Authors: Yuki Hara, Rin Yamaguchi, Ryota Otsubo, Ayako Fukushima, Eiko Inamasu, Momoko Akashi, Michi Morita, Sayaka Kuba, Susumu Eguchi, Keitaro Matsumoto
Year: 2024

7. Efficacy of chemically induced human hepatic progenitor cells from diseased liver against nonalcoholic steatohepatitis model

Authors: Daisuke Miyamoto, Kunihito Matsuguma, Kazuhiro Nagai, Takayuki Miyoshi, Takanobu Hara, Hajime Matsushima, Akihiko Soyama, Takahiro Ochiya, Yasushi Miyazaki, Susumu Eguchi
Year: 2024

8. Current status and future perspectives of robotic liver surgery

Authors: Akihiko Soyama, Takashi Hamada, Tomohiko Adachi, Susumu Eguchi
Year: 2024

9. Essential updates 2022/2023: A review of current topics in robotic hepatectomy

Authors: Tomohiko Adachi, Takanobu Hara, Hajime Matsushima, Akihiko Soyama, Susumu Eguchi
Year: 2024

10. Short‐term outcomes after liver resection with vascular reconstruction: Results from a study with the National Clinical Database of Japan

Authors: Akihiko Soyama, Hiroyuki Yamamoto, Susumu Eguchi, Atsushi Nanashima, Yoshihiro Kakeji, Yuko Kitagawa, Masafumi Nakamura, Itaru Endo
Year: 2024

Carmine Siniscalchi | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Carmine Siniscalchi | Medicine and Dentistry | Best Researcher Award

Medical Director from University of Parma, Italy

Dr. Carmine Siniscalchi is a distinguished medical researcher and physician specializing in internal medicine and cardiovascular diagnostics. With a career rooted in both academic excellence and clinical practice, he has demonstrated a strong commitment to advancing patient care through evidence-based research. Dr. Siniscalchi has authored 87 peer-reviewed publications indexed in Scopus, accumulating 722 citations and an h-index of 13—clear indicators of his research impact in the medical community. His expertise spans multiple domains including non-invasive cardiovascular imaging, thromboembolic disease, geriatric care, and the clinical implications of infectious diseases such as COVID-19. In addition to his research work, he has played a vital academic role as a contract professor and thesis advisor at the University of Parma. Through national and international collaborations, Dr. Siniscalchi has contributed to multidisciplinary studies that bridge clinical diagnostics with population health. His ability to integrate bedside ultrasonography, statistical methodologies, and epidemiological insights into routine practice underscores his innovative and patient-centered approach. With continued scholarly engagement and a forward-thinking mindset, he is well-positioned to make enduring contributions to medical science and education.

Professional Profile

Education

Dr. Carmine Siniscalchi’s academic background is marked by distinction and progressive specialization in the medical sciences. He earned his Medical Degree (Laurea Magistrale in Medicina e Chirurgia) with a score of 110/110 cum laude and special mention from the University of Campania Luigi Vanvitelli in 2009. Following this, he completed his specialization in Internal Medicine at the University of Parma in 2015, again achieving the highest marks with honors. He further pursued a Doctorate (Ph.D.) in Medical Sciences at the Department of Medicine and Surgery, University of Parma, which he completed with distinction in 2017. His doctoral research focused on the comparative efficacy of stress scintigraphy and contrast stress echocardiography in predicting cardiac events. To enhance his methodological expertise, he obtained a Second-Level Master’s Degree in Epidemiology and Biostatistics for Clinical Research from the University of Milano-Bicocca in 2021. This multidisciplinary academic progression has provided him with a strong foundation in both clinical practice and research methodology. Additionally, his classical high school education at Liceo Classico A. Rosmini of Palma Campania enriched his analytical and linguistic abilities, further supporting his academic career.

Professional Experience

Dr. Carmine Siniscalchi has built a multifaceted professional career combining clinical practice, academic teaching, and collaborative research. Since May 2022, he has served as a Contract Professor in Internal Medicine at the University of Parma’s School of Specialization in Cardiovascular Diseases. In this role, he actively contributes to the training of future medical specialists and supervises graduate and postgraduate thesis projects. His professional experience also includes participation in numerous interdisciplinary research projects at both national and international levels, with a strong focus on cardiovascular imaging and diagnostic techniques. Dr. Siniscalchi has held various roles in hospital settings, particularly focusing on internal medicine and geriatric care. His clinical work is deeply informed by his academic pursuits, allowing him to apply advanced diagnostics such as stress echocardiography and bedside ultrasonography in everyday practice. His capacity to balance medical education, clinical responsibility, and active research highlights his comprehensive professional competence. He is also noted for fostering international collaborations, contributing to peer-reviewed publications, and engaging in evidence-based improvements in patient care, particularly for complex cases involving multimorbidity and frailty in elderly populations.

Research Interests

Dr. Carmine Siniscalchi’s research interests are rooted in clinical relevance, focusing on improving diagnostic accuracy and therapeutic strategies in internal medicine. One of his primary interests lies in non-invasive cardiovascular diagnostics, particularly stress echocardiography and scintigraphy, for risk stratification in coronary artery disease. He has also explored the use of bedside ultrasonography as a decision-making tool in hospital settings. His work extends to thromboembolic diseases, both acute and chronic, with emphasis on diagnosis, treatment, and patient outcomes. In recent years, he has actively investigated cardiovascular risk assessment during pregnancy, contributing to studies on maternal cardiac adaptation. A significant portion of his research is also devoted to geriatrics, including the clinical management of frail and multimorbid elderly patients and the impact of hospital-acquired infections, including COVID-19, in this vulnerable population. His background in epidemiology and biostatistics enables him to design and interpret studies that integrate clinical practice with public health implications. Through interdisciplinary collaboration, Dr. Siniscalchi seeks to bridge gaps between imaging technology, clinical decision-making, and long-term patient outcomes. His goal is to foster research that directly improves diagnostic pathways and therapeutic efficacy across diverse patient populations.

Research Skills

Dr. Siniscalchi possesses a robust and diverse set of research skills that align with his multidisciplinary academic and clinical profile. He is adept in epidemiological research design, biostatistics, and data interpretation, all enhanced by his advanced training in epidemiology from the University of Milano-Bicocca. His expertise in cardiovascular imaging, including stress echocardiography, pulse-cancellation echocardiography, and computed tomography, enables him to lead and contribute to high-impact diagnostic studies. He is skilled in conducting bedside ultrasonographic assessments, which he utilizes both as a clinical tool and a subject of investigation. His experience with manuscript writing, peer-reviewed publishing, and academic mentoring reflects his strong academic communication skills. Additionally, he has effectively managed collaborative research projects, integrating input from multi-center teams. His familiarity with scientific databases such as PubMed, Scopus, and Web of Science allows for rigorous literature review and citation analysis. Furthermore, Dr. Siniscalchi has shown proficiency in mentorship, having supervised multiple medical and specialty theses. His ability to bridge clinical insight with methodological precision makes him a valuable contributor to translational medical research.

Awards and Honors

Dr. Carmine Siniscalchi has been consistently recognized for his academic excellence and research acumen throughout his career. He graduated with honors in both his undergraduate and postgraduate medical education, earning a Laurea Magistrale cum laude with special mention and completing his Specialization in Internal Medicine and Ph.D. in Medical Sciences with top honors. While formal awards such as named prizes or competitive grants are not detailed in the available profile, the quality of his academic achievements and consistent recognition by examination commissions reflect a strong professional standing. His invitation to serve as a Contract Professor and his repeated role as thesis advisor indicate trust in his expertise and mentorship within the academic community. His publications in high-impact journals and collaborations with leading researchers further underscore his professional credibility. Being positioned as first, second, or corresponding author in key studies also highlights his leadership in research initiatives. As his career continues to evolve, more formal honors such as awards from scientific societies or recognition at international conferences are likely to follow, given his current trajectory and consistent scholarly output.

Conclusion

Dr. Carmine Siniscalchi exemplifies the qualities of an accomplished medical researcher and educator, with a strong foundation in clinical practice and a deep commitment to advancing diagnostic methodologies and patient care. His academic credentials, professional appointments, and impactful research contributions—particularly in cardiovascular diagnostics and internal medicine—make him a compelling candidate for recognition such as the Best Researcher Award. Through active involvement in teaching, publication, and collaborative research, he has demonstrated a balance of scholarly rigor and clinical pragmatism. While there is scope for further recognition through competitive awards and international grants, Dr. Siniscalchi’s current record already reflects significant contributions to the field. His ability to mentor students, collaborate across institutions, and address critical healthcare issues—ranging from cardiovascular risk to aging populations—positions him as a leader in translational medical research. In summary, Dr. Siniscalchi not only meets the standards of research excellence but also brings a humanistic and evidence-driven perspective to medicine, making him a strong nominee for distinguished honors in his field.

Publications Top Notes

  1. Title: Low-Density Lipoprotein Cholesterol Levels and Bleeding Risk in Venous Thromboembolism
    Authors: Carmine Siniscalchi, Tiziana Meschi, Pierpaolo Di Micco, Joaquín Alfonso-Megido, Manuel Monreal
    Journal: JAMA Network Open
    Year: 2025

  2. Title: Venous Thromboembolism in Patients Aged ≥90 Years: Trends in Clinical Features, Treatment, and Outcomes—RIETE Registry
    Authors: Ludovic Lafaie, Géraldine Poénou, Olivier Hanon, Alberto Rivera-Gallego, Ana Rodríguez-Cobo
    Journal: Journal of the American Geriatrics Society
    Year: 2025
    Citations: 2

  3. Title: Predictors of Acute Myocardial Infarction: A Machine Learning Analysis After a 7-Year Follow-Up
    Authors: Marco Casciaro, Pierpaolo Di Micco, Alessandro Tonacci, Sebastiano Gangemi, E. Imbalzano
    Journal: Clinics and Practice
    Year: 2025

  4. Title: Integrated Lung, Diaphragm and Lower Limb Muscular Ultrasound: Clinical Correlations in Geriatric Patients with Acute Respiratory Illness
    Authors: Nicoletta Cerundolo, Carmine Siniscalchi, Chukwuma Okoye, Andrea Nouvenne, Andrea Ticinesi
    Journal: Diagnostics
    Year: 2025

  5. Title: Baseline Hemoglobin Values and Clinical Outcomes in Acute Venous Thromboembolism: Insights From the RIETE Registry
    Authors: Carmine Siniscalchi, Pierpaolo Di Micco, Antonella Tufano, Pablo Javier Marchena, Mar Martín del Pozo
    Year: 2025

  6. Title: The Prognostic Value of Clinical Frailty Scale in COVID-19 Pneumonia Across Different Pandemic Phases: A Comparison Between the First and the Fourth Wave
    Authors: Carmine Siniscalchi, Andrea Ticinesi, Angela Guerra, Emanuela Porro, Tiziana Meschi
    Journal: Frontiers in Medicine
    Year: 2025

  7. Title: Proprotein Convertase Subtilisin/Kexin Type 9: A Promising Marker of Cardiovascular Risk in Post-Menopausal Diabetic Women in Primary Prevention
    Authors: Michelangelo Rottura, Maria Antonietta Barbieri, Carmine Siniscalchi, Natasha Irrera, E. Imbalzano
    Journal: Frontiers in Medicine
    Year: 2025

  8. Title: Gut Microbiome and Bone Health: Update on Mechanisms, Clinical Correlations, and Possible Treatment Strategies
    Authors: Andrea Ticinesi, Carmine Siniscalchi, Tiziana Meschi, A. Nouvenne
    Year: 2025
    Citations: 1

  9. Title: Antithrombotic Treatment in Antiphospholipid Syndrome: A Review
    Authors: Carmine Siniscalchi, Francesca Futura Bernardi, Pierpaolo Di Micco, Tiziana Meschi, Ugo Trama
    Year: 2025

 

Huan-You Wang | Health Professions | Best Academic Researcher Award

Posted on by Shen Awards

Prof. Huan-You Wang | Health Professions | Best Academic Researcher Award

Professor of Pathology, Director of Hematopathology Fellowship, Associate Vice Chair for Education and Academic Affairs, University of California San Diego, United States

Dr. Huan-You Wang is a distinguished Clinical Professor of Pathology at the University of California, San Diego (UCSD), where he also serves as the Medical Director of the Clinical Hematology Laboratory. With an extensive career in academic medicine and clinical diagnostics, Dr. Wang has made significant contributions to the field of hematopathology. His research primarily focuses on hematologic malignancies, including leukemia, lymphoma, and myelodysplastic syndromes. Dr. Wang’s expertise encompasses molecular diagnostics, flow cytometry, and the integration of advanced genomic techniques into clinical practice. He has authored over 160 peer-reviewed publications, reflecting his commitment to advancing medical knowledge and improving patient care. Beyond his clinical and research endeavors, Dr. Wang has played a pivotal role in medical education, mentoring numerous trainees and contributing to the development of pathology fellowship programs at UCSD. His leadership extends to professional organizations, having served as the President of the Chinese American Pathologists Association (CAPA) from 2019 to 2020. Dr. Wang’s dedication to excellence in pathology has earned him recognition as a leader in his field, influencing both national and international practices in hematopathology.

Professional Profile

Education

Dr. Wang’s academic journey began at Tongji Medical University in Wuhan, China, where he served as a Graduate Research Associate in the Department of Pathology from 1987 to 1990. He then held an instructor position at Peking University Health Sciences Center in Beijing from 1990 to 1992. Pursuing advanced education, Dr. Wang completed his MD and PhD at the University of California, San Diego, specializing in Molecular Pathology and Cellular and Molecular Medicine between 1994 and 2000. This rigorous training provided him with a robust foundation in both clinical medicine and biomedical research, equipping him with the skills necessary to excel in the complex field of hematopathology. His educational background reflects a blend of international experience and interdisciplinary expertise, contributing to his comprehensive approach to pathology and research.

Professional Experience

Dr. Wang’s professional career is marked by a series of esteemed positions in academic and clinical settings. From 2005 to 2009, he served as an Assistant Professor of Pathology at the University of Texas Southwestern Medical Center in Richardson, Texas. In 2009, he joined the University of California, San Diego, where he currently holds the position of Clinical Professor of Pathology. At UCSD, Dr. Wang also serves as the Medical Director of the Clinical Hematology Laboratory, overseeing diagnostic services and contributing to the advancement of laboratory practices. His roles have encompassed clinical diagnostics, research, and education, reflecting a commitment to integrating scientific discovery with patient care. Dr. Wang’s leadership in these capacities has significantly influenced the development of pathology services and the training of future medical professionals.

Research Interests

Dr. Wang’s research interests are centered on the pathogenesis and diagnosis of hematologic malignancies. He has extensively studied various forms of leukemia and lymphoma, focusing on the molecular and cellular mechanisms underlying these diseases. His work often involves the application of advanced techniques such as flow cytometry, molecular diagnostics, and genomic analysis to improve diagnostic accuracy and patient outcomes. Dr. Wang is particularly interested in the identification of novel biomarkers and therapeutic targets, aiming to enhance personalized medicine approaches in hematopathology. His research contributes to a deeper understanding of disease processes and the development of innovative diagnostic and treatment strategies.

Research Skills

Dr. Wang possesses a comprehensive skill set that encompasses various methodologies essential to modern pathology research. His expertise includes flow cytometry, which he utilizes for immunophenotypic analysis of hematologic malignancies. He is proficient in molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), enabling the detection of genetic mutations and chromosomal abnormalities. Dr. Wang also employs immunohistochemistry for the characterization of tissue samples, contributing to accurate disease classification. His skills extend to the interpretation of complex data sets, integrating clinical findings with laboratory results to inform diagnostic and therapeutic decisions. This multifaceted expertise allows Dr. Wang to conduct comprehensive research that bridges laboratory science and clinical application.

Awards and Honors

Throughout his career, Dr. Wang has received numerous accolades recognizing his contributions to pathology and medical research. Notably, he served as the President of the Chinese American Pathologists Association (CAPA) from 2019 to 2020, reflecting his leadership and commitment to the professional community. His extensive publication record, comprising over 160 peer-reviewed articles, underscores his influence in the field and dedication to advancing scientific knowledge. Dr. Wang’s work has garnered citations and recognition from peers, highlighting the impact of his research on the understanding and management of hematologic diseases. These honors attest to his role as a leading figure in pathology, contributing to both academic excellence and clinical innovation.

Conclusion

Dr. Huan-You Wang’s career exemplifies a harmonious blend of clinical practice, research, and education in the field of pathology. His dedication to understanding hematologic malignancies has led to significant advancements in diagnostic methodologies and patient care. Through his leadership roles, including his tenure as President of CAPA, Dr. Wang has influenced the direction of pathology practice and fostered professional development within the community. His commitment to mentorship and education ensures the cultivation of future experts in the field. Dr. Wang’s contributions continue to shape the landscape of hematopathology, reflecting a career devoted to scientific inquiry, clinical excellence, and the betterment of patient outcomes.

Publications Top Notes

  1. Title: Isolated Monoclonal T-Cell Receptor Gene Rearrangement in a Lung Adenocarcinoma Harboring MET Exon 14 Skipping: Diagnostic Pitfall
    Authors: Shi, Wangpan Jackson; Nguyen, Joshua J.; Song, Wei W.; Fadare, Oluwole O.; Lei, Li L.
    Journal: International Journal of Surgical Pathology
    Year: 2025

  2. Title: Intratumoral Injection of Cytotoxic Drugs Plus Hapten Elicits Significant Immune Responses in Sentinel Lymph Nodes: Implications for Cancer Immunotherapy
    Authors: Yu, Baofa B.; Zhang, Jian J.; Han, Yan Y.; Zhou, Shengjun S.; Wang, Huanyou H.
    Journal: Pancreas
    Year: 2025

  3. Title: Erythroblastic Sarcoma in Adults and Children: Different Pathways to the Same Destination
    Authors: Fitzpatrick, Megan J.; Yuan, Ji J.; Capa, Ioana I.; Medeiros, Leonard Jeffrey L.; Pan, Zenggang Z.
    Journal: Modern Pathology
    Year: 2025

  4. Title: Mutation in Bruton Tyrosine Kinase (BTK) A428D Confers Resistance to BTK-Degrader Therapy in Chronic Lymphocytic Leukemia
    Authors: Wong, Richard L.; Choi, Michael Youngjun M.Y.; Wang, Huanyou H.; Kipps, Thomas J.
    Type: Letter
    Year: 2025
    Citations: 9

  5. Title: A CD10-Negative Adult B-Lymphoblastic Leukemia with Amplification of KMT2A Without Rearrangement: A Case Report and Review of the English Literature
    Authors: Wang, Huanyou H.; Louis, Hailee M.St H.M.S.; Costello, Caitlin L.C.L.; Murray, Sarah Shaw S.S.; Dell’Aquila, Marie L.M.L.
    Year: 2025

  6. Title: Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract—What Have We Learned in the Last Decade?
    Authors: Wang, Xingen X.; Yin, Weihua W.; Wang, Huanyou H.
    Type: Review
    Year: 2025

  7. Title: Nuclear Morphology is Shaped by Loop-Extrusion Programs
    Authors: Patta, Indumathi I.; Zand, Maryam M.; Lee, Lindsay L.; Hu, Ming M.; Murre, Cornelis C.
    Journal: Nature
    Year: 2024
    Citations: 3

  8. Title: IDH2-Mutated Near ETP-ALL with Aggressive Leukemia Cutis and Brisk Response to Venetoclax and Decitabine
    Authors: Vaidya, Poorva P.; Wang, Huanyou H.; Don, Michelle D.M.D.; Hinds, Brian R.B.R.; Mangan, James K.J.K.
    Journal: Leukemia Research Reports
    Year: 2024
    Citations: 1

  9. Title: Myeloid Lineage Switch Following CD7-Targeted Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia
    Authors: Aldoss, Ibrahim T.I.T.; Tizro, Parastou P.; Bedi, Davsheen D.; Wang, Huanyou H.; Afkhami, Michelle M.
    Journal: Haematologica
    Year: 2023
    Citations: 3

  10. Title: A Cell-Level Discriminative Neural Network Model for Diagnosis of Blood Cancers
    Authors: Robles, Edgar E.E.; Jin, Ye Y.; Smyth, Padhraic P.; Oak, Jean S.J.S.; Qian, Yu Y.
    Journal: Bioinformatics
    Year: 2023
    Citations: 4